AMNEAL PHARMACEUTICALS, INC. (AMRX) /
The cash flow of AMNEAL PHARMACEUTICALS, INC. over the past 10 years
Chart AMNEAL PHARMACEUTICALS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, AMNEAL PHARMACEUTICALS, INC.'s operating cash flow was $339.99M and its capital expenditures $70.06M, leaving free cash flow of $269.93M. Free cash flow was above zero in 8 of the 10 years shown. It ranged from -$45.48M in fiscal 2019 to $322.56M in fiscal 2020. Capital expenditures were highest in fiscal 2016, at $122.76M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $339.99M | $70.06M | $269.93M |
| 2024ended Dec 31, 2024 | $295.1M | $51.92M | $243.18M |
| 2023ended Dec 31, 2023 | $345.58M | $43.22M | $302.36M |
| 2022ended Dec 31, 2022 | $65.1M | $46.41M | $18.69M |
| 2021ended Dec 31, 2021 | $241.82M | $47.73M | $194.09M |
| 2020ended Dec 31, 2020 | $379M | $56.45M | $322.56M |
| 2019ended Dec 31, 2019 | $1.71M | $47.18M | -$45.48M |
| 2018ended Dec 31, 2018 | $250.23M | $83.09M | $167.14M |
| 2017ended Dec 31, 2017 | $234.19M | $94.77M | $139.42M |
| 2016ended Dec 31, 2016 | $115.06M | $122.76M | -$7.7M |
Fiscal years as AMNEAL PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AMNEAL PHARMACEUTICALS, INC.
- The revenue of AMNEAL PHARMACEUTICALS, INC.
- The profitability of AMNEAL PHARMACEUTICALS, INC.
- The debt of AMNEAL PHARMACEUTICALS, INC.
- All of AMNEAL PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- PPCPILGRIM’S PRIDE CORPORATION
- FAFFIRST AMERICAN FINANCIAL CORPORATION
- ACTEnact Holdings, Inc.
- LADLithia Motors, Inc.
- UBSIUNITED BANKSHARES INC/WV
Not investment advice. This page shows what AMNEAL PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.